Parathyroid and Thymus Transplantation in DiGeorge #931
Parathyroid and Thymus Transplantation in DiGeorge Syndrome, #931
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
A PHASE1 clinical study on Complete DiGeorge Syndrome and DiGeorge Syndrome, this trial is completed. The trial is conducted by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and has accumulated 11 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Feb 2024 — Jul 2024 [monthly]
Completed PHASE1
-
May 2022 — Feb 2024 [monthly]
Completed PHASE1
-
Jan 2022 — May 2022 [monthly]
Completed PHASE1
▶ Show 6 earlier versions
-
Jan 2021 — Jan 2022 [monthly]
Completed PHASE1
-
May 2020 — Jan 2021 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Jun 2019 — May 2020 [monthly]
Active Not Recruiting PHASE1
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE1
First recorded
Jan 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Food and Drug Administration (FDA)
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Institutes of Health (NIH)
- Sumitomo Pharma Switzerland GmbH
For direct contact, visit the study record on ClinicalTrials.gov .